{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:48:05Z","timestamp":1755222485412,"version":"3.43.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,10]]},"DOI":"10.7759\/cureus.89753","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T02:16:04Z","timestamp":1754878564000},"source":"Crossref","is-referenced-by-count":0,"title":["Isolated Rapidly Progressive Interstitial Lung Disease Without Muscle or Skin Involvement in Idiopathic Inflammatory Myopathy: An Unusual Anti-Mi-2 Antibody Phenotype"],"prefix":"10.7759","author":[{"given":"Rajesh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruthra","family":"Kumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanchan K","family":"Kujur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2478\/rir-2022-0001","article-title":"Myositis-specific Antibodies: overview and clinical utilization","volume":"3","author":"Halilu F","year":"2022","unstructured":"Halilu F, Christopher-Stine L. Myositis-specific Antibodies: overview and clinical utilization. Rheumatol Immunol Res. 2022, 3:1-10. 10.2478\/rir-2022-0001","journal-title":"Rheumatol Immunol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2020.3750","article-title":"Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis (online ahead of print)","volume":"30","author":"Liang L","year":"2020","unstructured":"Liang L, Zhang YM, Chen H, et al.. Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis (online ahead of print). Eur J Dermatol. 2020, 30:151-8. 10.1684\/ejd.2020.3750","journal-title":"Eur J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/08916930400022681","article-title":"Anti-Mi-2 antibodies","volume":"38","author":"Ghirardello A","year":"2005","unstructured":"Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Bendo R, Gambari PF, Doria A. Anti-Mi-2 antibodies. Autoimmunity. 2005, 38:79-83. 10.1080\/08916930400022681","journal-title":"Autoimmunity"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.41105","article-title":"Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti-melanoma differentiation-associated gene 5-positive dermatomyositis","volume":"72","author":"Tsuji H","year":"2020","unstructured":"Tsuji H, Nakashima R, Hosono Y, et al.. Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti-melanoma differentiation-associated gene 5-positive dermatomyositis. Arthritis Rheumatol. 2020, 72:488-98. 10.1002\/art.41105","journal-title":"Arthritis Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome","volume":"13","author":"Lega JC","year":"2014","unstructured":"Lega JC, Fabien N, Reynaud Q, et al.. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmun Rev. 2014, 13:883-91. 10.1016\/j.autrev.2014.03.004","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2174\/157339710791330740","article-title":"Interstitial lung disease in idiopathic inflammatory myopathy","volume":"6","author":"Saketkoo LA","year":"2010","unstructured":"Saketkoo LA, Ascherman DP, Cottin V, Christopher-Stine L, Danoff SK, Oddis CV. Interstitial lung disease in idiopathic inflammatory myopathy. Curr Rheumatol Rev. 2010, 6:108-19. 10.2174\/157339710791330740","journal-title":"Curr Rheumatol Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/brvl1v","article-title":"Myositis-associated interstitial lung disease: a comprehensive approach to diagnosis and management","volume":"40","author":"Hallowell RW","year":"2022","unstructured":"Hallowell RW, Paik JJ. Myositis-associated interstitial lung disease: a comprehensive approach to diagnosis and management. Clin Exp Rheumatol. 2022, 40:373-83. 10.55563\/clinexprheumatol\/brvl1v","journal-title":"Clin Exp Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq149","article-title":"Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis","volume":"49","author":"Gono T","year":"2010","unstructured":"Gono T, Kawaguchi Y, Satoh T, et al.. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford). 2010, 49:1713-9. 10.1093\/rheumatology\/keq149","journal-title":"Rheumatology (Oxford)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2017.06.007","article-title":"Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort","volume":"84","author":"Tansley SL","year":"2017","unstructured":"Tansley SL, Simou S, Shaddick G, et al.. Autoantibodies in juvenile-onset myositis: their diagnostic value and associated clinical phenotype in a large UK cohort. J Autoimmun. 2017, 84:55-64. 10.1016\/j.jaut.2017.06.007","journal-title":"J Autoimmun"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/394767-isolated-rapidly-progressive-interstitial-lung-disease-without-muscle-or-skin-involvement-in-idiopathic-inflammatory-myopathy-an-unusual-anti-mi-2-antibody-phenotype","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T02:16:07Z","timestamp":1754878567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/394767-isolated-rapidly-progressive-interstitial-lung-disease-without-muscle-or-skin-involvement-in-idiopathic-inflammatory-myopathy-an-unusual-anti-mi-2-antibody-phenotype"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,10]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.89753","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,10]]}}}